Efficacy and safety of BORTEZOMIB treatment for refractory acute antibody-mediated rejection-a pilot study.

Slatinska, Janka

Efficacy and safety of BORTEZOMIB treatment for refractory acute antibody-mediated rejection-a pilot study. [electronic resource] - HLA 12 2018 - 47-50 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2059-2310

10.1111/tan.13387 doi


Adrenal Cortex Hormones--therapeutic use
Adult
Bortezomib--therapeutic use
Drug Administration Schedule
Female
Graft Rejection--blood
Graft Survival
HLA Antigens--genetics
Histocompatibility Testing--methods
Humans
Immunologic Factors--therapeutic use
Isoantibodies--blood
Kidney Transplantation
Male
Middle Aged
Patient Safety
Pilot Projects
Plasmapheresis--methods
Prognosis
Rituximab--therapeutic use
Tissue Donors
Transplantation, Homologous
Treatment Outcome